Skip to main content
Equibles

BNP PARIBAS ARBITRAGE, SA

Position in VCEL — Vericel Corp

CIK 1166588 NEW YORK, NY
Back to VCEL Full portfolio

Position in VCEL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$5,573,395
+$2,218,483 QoQ
Shares Held
125,273
+20.1% QoQ
Ownership
0.245%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#64
of 317 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in VCEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BNP PARIBAS ARBITRAGE, SA holds $3,331,911,027 across 414 Biotechnology names. VCEL ranks #73 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MRNA
Moderna, Inc.
 4,377,120 $306,529,713
2 REGN
Regeneron Pharmaceuticals, Inc.
 399,847 $249,320,598
3 ARGX
Argenx SE
 157,958 $146,548,693
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 262,258 $130,271,416
5 BNTX
BioNTech SE
 1,319,517 $122,781,056
6 RVMD
Revolution Medicines, Inc.
 552,710 $103,511,528
7 ORKA
Oruka Therapeutics, Inc.
 1,079,015 $102,689,857
8 BBIO
BridgeBio Pharma, Inc.
 1,155,442 $86,057,320

All Filings in VCEL

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,573,395 125,273
2026-03-31 $3,354,912 104,287
2025-12-31 $2,826,244 78,485
2025-09-30 $1,828,123 58,091
2025-06-30 $1,322,539 31,082
2025-03-31 $180,264 4,040
2024-12-31 $1,136,582 20,699
2024-09-30 $1,347,817 31,901
2024-06-30 $2,958,938 64,493
2024-03-31 $5,813,755 111,760
2023-12-31 $1,992,878 55,964
2023-09-30 $1,642,345 48,996
2023-06-30 $1,155,991 30,769
2023-03-31 $1,698,566 57,932
2022-12-31 $1,093,531 41,516
2022-09-30 $1,296,184 55,870
2022-06-30 $812,281 32,259
2022-03-31 $445,798 11,664
2021-12-31 $835,164 21,251
2021-09-30 $2,192,291 44,924
2021-06-30 $3,020,850 57,540
2021-03-31 $2,678,509 48,218
2020-12-31 $2,925,756 94,746
2020-09-30 $195,843 10,569
2020-06-30 $85,684 6,200
2020-03-31 $198,961 21,697